Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00007
|
|||||
Drug Name |
Prostaglandin f2Alpha
|
|||||
Synonyms |
Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Solid tumours [ICD11: 2D4Z] | Preclinical | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H34O5
|
|||||
Canonical SMILES |
CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O
|
|||||
InChI |
InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1
|
|||||
InChIKey |
PXGPLTODNUVGFL-YNNPMVKQSA-N
|
|||||
CAS Number |
CAS 551-11-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 354.5 | Topological Polar Surface Area | 98 | ||
Heavy Atom Count | 25 | Rotatable Bond Count | 12 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
2.7
|
|||||
PubChem CID | ||||||
PubChem SID |
103214323
, 103943633
, 104046437
, 113853160
, 124892254
, 124892255
, 125307573
, 126662422
, 134340899
, 134978425
, 135651540
, 137006907
, 142063920
, 144205330
, 14852168
, 15398784
, 162205063
, 175268163
, 175607780
, 176484109
, 179116866
, 211534905
, 223673680
, 226412676
, 26754609
, 29216066
, 3912
, 39289529
, 4265953
, 47588758
, 47588759
, 48258963
, 48415906
, 50026801
, 50110092
, 53789218
, 56311306
, 56313004
, 56313208
, 57357710
, 613198
, 77668180
, 7847149
, 7980284
, 8143215
, 8616237
, 92308787
, 92309910
, 99300824
, 99302342
|
|||||
ChEBI ID |
CHEBI:15553
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | MRP4 | Transporter Info | Multidrug resistance-associated protein 4 | Substrate | [2] | |
OAT1 | Transporter Info | Organic anion transporter 1 | Substrate | [3] | ||
OAT2 | Transporter Info | Organic anion transporter 2 | Substrate | [4] | ||
OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [3] | ||
OAT4 | Transporter Info | Organic anion transporter 4 | Substrate | [3] | ||
OATP2A1 | Transporter Info | Organic anion transporting polypeptide 2A1 | Substrate | [5] | ||
OATP3A1 | Transporter Info | Organic anion transporting polypeptide 3A1 | Substrate | [6] | ||
OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [3] | ||
OCT-2 | Transporter Info | Organic cation transporter 2 | Substrate | [3] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | OAT1 | Transporter Info | Km = 0.575 microM | Proximal tubule (S2) cells-OAT1 | [3] | |
OAT2 | Transporter Info | Km = 0.425 microM | Proximal tubule (S2) cells-OAT2 | [4] | ||
OAT3 | Transporter Info | Km = 1.092 microM | Proximal tubule (S2) cells-OAT3 | [3] | ||
OAT4 | Transporter Info | Km = 0.692 microM | Proximal tubule (S2) cells-OAT4 | [3] | ||
OCT-1 | Transporter Info | Km = 0.477 microM | Proximal tubule (S2) cells-OCT1 | [3] | ||
OCT-2 | Transporter Info | Km = 0.344 microM | Proximal tubule (S2) cells-OCT2 | [3] | ||
References | ||||||
1 | Stereocontrolled organocatalytic synthesis of prostaglandin PGF2alpha in seven steps. Nature. 2012 Sep 13;489(7415):278-81. | |||||
2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. | |||||
3 | Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther. 2002 Apr;301(1):293-8. | |||||
4 | Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther. 2002 Jun;301(3):797-802. | |||||
5 | Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest. 1996 Sep 1;98(5):1142-9. | |||||
6 | Molecular characterization of human and rat organic anion transporter OATP-D. Am J Physiol Renal Physiol. 2003 Dec;285(6):F1188-97. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.